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Background: This study was conducted to explore new approaches of animal biocontrol via biological
control feed.
Method: White rats were subjected to 140 highly lytic designed phages specific against E. coli. Phages were fed via
drinking water, oral injection, and vegetable capsules. Phage feeding was applied by 24 h feeding with 11d
monitoring and 20d phage feeding and monitoring. Group of rats received external pathogenic E. coli and another
group did not, namely groups A and B.
Results: Phage feeding for 20d via vegetable capsules yielded the highest reduction of fecal E. coli, 3.02 and 4.62
log, in rats group A and B respectively. Second best, feeding for 20d via drinking water with alkali yielded 2.78 and
4.08 log in rats groups A and B respectively. The peak reduction in E. coli output was 5–10 d after phage feeding.
Phage control declined after 10th day of feeding.
Conclusions: The use of cocktail of designed phages succeeded in suppressing flora or external E. coli. The phage
feed biocontrol is efficient in controlling E. coli at the pre-harvest period, precisely at the 6th-8th day of phage
feeding when the lowest E. coli output found.
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Escherichia coli (E. coli) is the predominant nonpatho-
genic facultative flora of the human and animal intestine
[1]. However, several strains of E. coli have developed
the ability to cause diseases in humans. Strains of E. coli
that cause gastroenteritis in humans can be grouped into
six categories: enteroaggregative (EAEC), enterohemor-
rhagic (EHEC), enteroinvasive (EIEC), enteropathogenic
(EPEC), enterotoxigenic (ETEC), and diffuse adherent
(DAEC) [1].
Among the most notorious, EHEC is a variety of E. coli
that produces large quantities of one or more related
potent toxins that cause severe damage to the lining of
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article, unless otherwise stated.of colorectum [2]. It is transmitted to humans through
contaminated food, water, and direct contact with in-
fected people or animals [3].
The infectious dose of EHEC and other pathogenic
E. coli is very low, under 100 organisms [4] which re-
quires stringent measures to decrease E. coli load from
animals and environment. The organism can be found
on most cattle farms and it is commonly found in pet-
ting zoos and can live in the intestines of healthy cattle,
deer, goats, and sheep [5]. Therefore, meat can become
contaminated during and after slaughtering, and organ-
isms can be accidentally mixed into meat when it is
ground [6]. Moreover, E. coli is highly present on the
cow’s udders or on equipment used in milking which
may get into raw milk [7]. Therefore, drinking milk or
eating meat, especially ground beef that has not been
cooked sufficiently to kill E. coli, can cause infection
given that contaminated meat looks and smells normal.
This problem has not yet been worked out due to thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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abolish the E. coli burden from animal gut before or dur-
ing slaughtering. Therefore, novel approaches of animal
biocontrol against E. coli might be necessary to pursue,
including bacteriophage-based biocontrol.
Phage biocontrol represents the application of specific
phages, which are pathogens of bacteria, to selectively
reduce or eliminate pathogen-susceptible organisms
from specific natural environments (e.g., the bodies
of humans and other animals), artificial environments
(e.g., farms, factories, offices, hospitals, etc.), or even
laboratory environments (e.g., to reduce streptomycete
numbers on soil dilution plates [8,9]. The ability of phages
to recognize precisely their hosts, rendered them as favor-
able antibacterial agents because broad-spectrum antibi-
otics kill target bacteria along with other beneficial bacteria
present in the farm or in the organism body, say intestinal
flora [10]. Many studies were applied mainly in the Soviet
Union counties showed that application of phages in
bacterial therapy or biocontrol is attainable in theory
but practicably results were not so successful due to the
lack of full coverage of target bacteria and the rapid
emergence of bacterial mutations leading to complete
resistance against phage infection [11-14]. Therefore,
phage therapy or phage biocontrol have become unsuc-
cessful [15] and eventually led to replacement of phage
therapy with antibiotic treatment [12].
The exploitation of bacteriophages as a realistic approach
to the control of pathogens has attracted considerable
interest in recent years [10,14] because of the emergence
of antibiotic resistant bacteria. For example, calves and
piglets with diarrhea due to experimentally administered
pathogenic E. coli were cured within 8 h following phage
administration [16]. Experimentally induced diarrhea
could be prevented by spraying the litter in the calf
rooms with aqueous phage suspensions or by keeping
calves in uncleaned rooms previously occupied by calves
whose E. coli infection had been treated by phage adminis-
tration [17]. Hence, elimination of the pathogenic E. coli
at the preharvest stage could play a significant role in pre-
venting its introduction the food chain [18]. Bactericidal
bacteriophages may provide a natural, nontoxic, feasible
approach for controlling several human pathogens [11]
since phages are part of both gastrointestinal and environ-
mental ecosystems [19].
Unfortunately, the lack of techniques to counter phage
sequestration, resistance, and conversion eventually led
to replacement of phage therapy with antibiotic treat-
ment [12]. However, with our exclusive knowledge of
phage breeding techniques, it may be possible to circum-
vent the problems encountered in previous attempts to
use phages as natural antimicrobial agents. In this study,
a cocktail of 140 specific lytic phages, which were pre-
viously optimized and bred by non-genetic breedingtechniques bacteria [IPO-UK Patent Application No.
0822068] was used in novel approaches in animal biocon-
trol and animal feed. White rats were used for testing the
animal feed with anti-E. coli phage cocktail. The intestinal
load of E. coli as well as experimentally inoculated human
pathogenic E. coli were then traced by microbiological
methods to estimate the phage-driven decline of the
E. coli microbial load in the treated animals.
Methods
Preparation of the anti- E. coli phage cocktail
Media
Luria broth (LB): tryptone 10 g l-1 (HiMedia, Mumbai,
India), yeast extract 5 g l-1 (HiMedia, Mumbai, India),
and sodium chloride 10 g l-1 (HiMedia, Mumbai, India) at
pH 7.2 were used in all the protocols. L-agar (LA), con-
sisted of the above with the addition of 14 g l-1 agar
(HiMedia, Mumbai, India) was used for culture mainten-
ance. Bacterial dilutions from 18 h LB cultures grown
at 37°C were carried out in phosphate buffered saline
(PBS, Oxoid, UK). For plaque assay, the ‘soft layer agar’
used was LB prepared in Lambda-buffer [6 mmol l-1
Tris pH 7.2, 10 mmol l-1 Mg(SO4)2.7H2O, 50 μg ml-1
gelatin (Oxoid, UK)], was supplemented with 4 g l-1 agar
bacteriology No. 1 (HiMedia, Mumbai, India).
Bacterial strains
Four hundred and thirty clinical isolates of EHEC and
non-EHEC E. coli were obtained from hospital inpatients
(Microbiology laboratories, Hospital Serdang and Hospital
Kajang in Selangor, Malaysia) including documented spor-
adic cases of haemorrhagic colitis, non-haemorrhagic col-
itis, urinary tract infections, infected wounds, vaginitis, and
bacteremic cases. They were reconfirmed by using Micro-
bact GNB 12A system (Oxoid, UK), a microtitre well-scaled
chemical test. Microbact system has 100% sensitivity for
identifying E. coli from other Enterobacteracea bacteria.
In addition, several E. coli reference strains were used:
one EHEC NTCC 129001 and five non-EHEC (two are
generic strains; ATCC 12799 and NTCC 9001, three
human enteropathogenic strains (EPEC); ATCC 12810,
ATCC 25922, and ATCC 35218 (zoonotic). Both E. coli
clinical isolates and representative NTCC and ATCC
E. coli strains were used throughout phage isolation,
propagation, optimization and breeding as described here.
The strains were maintained on L-agar plates and trans-
ferred bimonthly. All cultures were stored at −20°C in
15% glycerol. Prior to investigation a stock culture of the
bacteria was maintained on LA plate. One loopful of the
bacterial strain was inoculated into a 100 ml Erlenmeyer
flask containing 10 ml of LB and incubated for 18 h at
37°C and 90 rev min-1 in an incubator shaker (Innova
4000, New Brunswick Scientific). For experimental
tests appropriate serial dilutions were made in LB.
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Wild bacteriophages (phage) used in this study were iso-
lated from and specifically designed for 430 clinical isolates
and 6 reference strains of EHEC (http://www.sumobrain.
com/patents/wipo/Methods-bacteriophage-design/WO201
0064044A1.pdf). The phage master mix was composed of
140 phages that were previously isolated, bred, and
produced by 2 types of novel, under patenting breeding
techniques (http://patentscope.wipo.int/search/en/WO1995
023848): chemical vertical breeding which is characterized
by enhancing the lytic infective criteria of the bred phages
in order to obtain optimized biokinetic potential and
chemical horizontal breeding which is characterized by al-
tering the specificity of the bred phages to be reoriented to
new strains of E. coli leading to wider coverage of target
bacteria (http://www.sumobrain.com/patents/wipo/Methods
-bacteriophage-design/WO2010064044A1.pdf). This break-
through technology opened doors for designing and
optimizing unprecedented phage applications including
eliminating the pathogenic EHEC and non-EHEC bacteria
from food, machinery tools, and medical instruments by
using high number of artificially bred specific phages. The
resultant phages were mixed together forming what is
called the ‘phage master mix’. The phage master mix was
composed of 140 highly lytic and specific bred phages.
Groups of tested animals
Two groups of albino rats, Rattus norvegicus, were sub-
jected for phage biocontrol against E. coli. Group A, rats
were fed with a phage cocktail of 140 phages without
prior oral inoculation with human pathogenic E. coli. In
this instance, the phage cocktail targets the naturally
resident E. coli bacteria inside the animals’ gut. Group B,
rats were fed for three weeks with phage cocktail of 140
phages along with, at the same time, oral inoculation of
60 human pathogenic E .coli isolates at concentration
108 colony forming unit /ml (CFU/ml) in drinking water.
Each inoculated E. coli isolate was recognized by three to
four phage members of the used phage master mix bac-
teria [IPO-UK Patent Application No. 0822068]. As many
animals act as reservoir for human pathogenic E. coli, group
B provides an opportunity to test the biocontrol effect of
the used phage cocktail against human E. coli pathogens
that reside in the intestine of animals (Figure 1).
The control versus phage-biocontrolled fecal output of E. coli
The magnitude of E. coli phage control was measured in
terms of log reduction (LR) of E. coli fecal output in
tested rats. The total fecal output of E. coli in rats was
estimated before and during the oral administration of the
phage master mix in order to determine the pre-treatment
level of E. coli as well as to determine the phage-based LR
of E. coli. For unloaded rats with pathogenic E. coli, group
A, the control fecal output of E. coli was measured intriplicate just before feeding the phages and was considered
as the baseline from which changes of phage-driven E. coli
output were measured in terms of LR in the same rats. For
rats preloaded with pathogenic E. coli, group B, were sub-
grouped into two sets. The first set, rats were not subjected
to phage feeding which were used to measure, in triplicate,
the control fecal output of the pathogenic plus resident
E. coli. The second set, rats were subjected to phage feeding
along with external E. coli inoculation. This set was used to
measure, in triplicate, the phage-driven reduction of fecal
output of E. coli in comparison with the first set.Measurement of the E. coli fecal output
The fecal output of E. coli was measured by taking 0.2 g
of feces diluted 1:5 w/v in PBS (Oxoid, UK). Afterwards, 10
ul of the net, 1:10, and 1:100 dilutions of the fecal solution
were spotted on MacConckey agar and were incubated
overnight at 43.4C. It is well known that E. coli bacteria are
the only lactose fermenter enterobacteriacae that able to
survive temperature of 43.4C. Next day, CFU were counted
per each spot of inoculation. The concentration of fecal
E. coli, in CFU/ml, was then calculated by incorporating the
dilution and volume factors. Hence, E. coli bacteria were
cultured selectively and then counted on daily basis.Methods of the phage feeding
Phage feeding of rat animals was conducted via three
methods. First, phage master mix was incorporated in
drinking water at concentration of 107 PFU/ml with/
without 6% w/v Sodium bicarbonate and fed to animals
via the rats’ water feeding bottle. In this way, rats took
the phage cocktail orally every time they drink water.
A group of rats was allowed to drink the phage-
containing water for only one d while another group
was allowed to drink the phage-containing water for 20
d in order to compare the phage-driven LR of fecal
output of E. coli between the single day and continuous
phage feedings. The second method of feeding of
phage cocktail was achieved by injecting the phage
master mix in lambda buffer at concentration of 107
PFU/ml directly through oral route by using rats’ feed-
ing bottles without further mixing with water. Four ml
of phages suspension in lambda buffer with 6% w/v So-
dium bicarbonate were managed to be injected orally
to rats 3 times a day at 2 h intervals for 20 d. The third
method of phage master mix feeding was done using
absorbable vegetable capsules (ZeinPharma Germany
GmbH, Germany) made of Hydroxypropyl Methylcel-
lulose (HPMC) administered orally into the tested rats.
Capsules were filled with 0.5 ml of phage cocktail in
lambda buffer, 106 PFU/ml of the phage master mix.
Rats were given 3 capsules a day at 2 h intervals for
20 d (Figure 1).
Figure 1 The outline of methodology for the phage feeding biocontrol of intestinal E. coli in white rats.
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animal feed
Different concentrations of phage master mix were evalu-
ated to determine the optimal concentration that results in
the best controlling effects of E. coli bacteria in rats’ intes-
tine. The phage preparation was composed of a collection
of 140 phages. Fifty ul from each bred phage were taken
and collected in a 15 ml sterile tube (Vivantis, Italy). The
phage cocktail was hence composed of 6 ml. According to
the method of phage administration, the final concentration
of phage feed was determined. In case of phage feeding
in drinkable water, 1 ml of 106–13 PFU/ml was added
to 299 ml of tap water, i.e., 1:300 dilution. Therefore,
the final concentration of phage-containing water was
103–10 PFU/ml. The standardization procedures in-
cluded administering phage cocktail via drinking water
continuously for four days using different phage con-
centrations, 103–10 PFU/ml. Then, the fecal output of
E. coli was evaluated by standard bacteriological methods.
It was shown that the increasing phage concentration gave
increasing E. coli lowering. Nevertheless, 107 PFU/ml led
to LR of E. coli similar to that of 106 PFU/ml and slightly
better than higher concentrations in both phage drinking
water and oral phage injection. Therefore, phage concen-
tration of 107 PFU/ml was considered optimal for phage
feeding via drinking water and lambda buffer oral injec-
tion. On the other hand, for phage containing capsules,
the standardization trials showed that the optimal concen-
tration of phage master mix was one log lower than that
used in drinking water or oral injection of lambda buffer,
namely 106 PFU/ml.Phage shedding
Along with monitoring the effect of the phage feeding on
the fecal output of E. coli in rat animals, the phage shed-
ding from the animals’ intestine was evaluated throughout
3 weeks of continuous phage feeding via drinking water.
The aim of this step was to assess the survival of the intro-
duced phages inside rats’ intestine and assess the relation-
ship between phage survival and its potential in lowering
the intestinal E. coli. An EHEC-specific coliphage, CEH-
183, was fed continuously with 6% w/v Sodium bicarbonate
via both drinking water and oral phage injection thrice a
day into rats that were previously fed with the target EHEC
bacteria, EH-138, for successive 3 days in order to prepare
the suitable host of the tested phage. On daily basis, 0.2 g
of feces was diluted 1:5 w/v in PBS. Ten ul of the net, 1:10,
and 1:100 dilutions of the fecal solution were then spotted
on an 18 h bacterial lawn of EH-183. Next day, the resulted
plaques were enumerated in each spot; the concentration
of shed phages was then calculated in terms of PFU/ml.
Therefore, the level of intestinal phage shedding was
evaluated with time to probe the effect of the immunity
of the tested animals on administered phages. Moreover,
the level of phage shedding was essential in giving the
optimal time for the peak phage replication and availabil-
ity inside animals’ intestine and testing whether this tim-
ing is coordinated with the optimal time of E. coli
lowering by the effect of fed phages or not. This was
important to determine the survival of phages and the
effect of the animals’ immunity on the phages survival.
This would help determine the exact timing of the
maximal phage biocontrol.
Table 2 LR of E. coli fecal output due to the effect of
single day feeding of phage master mix
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The data was analyzed and graphics were produced
using SPSS software version 12.0.0.1 as well as MS
EXCEL software version 2000. Logarithmic values in
terms of log10 CFU/ml and log10 PFU/ml for bacterial
and phage concentrations respectively were used. The
logarithmic mean, mean log10 CFU/ml or mean log10
PFU/ml, were calculated by averaging the individual
log10 CFU/ml or log10 PFU/ml values [20]. The mean
log reduction (LR) in CFU/ml was calculated by sub-
tracting the mean log10 CFU/ml of negative control
from mean log10 CFU/ml of test samples. Mean LR
CFU/mL ≥ 1 was considered as significant. The stand-
ard error (SE) of mean LR was calculated according to
the following equation [20]:
SE ¼
h
Variance mean log10CFU=mL control  N
 
þ Variance mean log10CFU=mL test  N
 i
sq: root
Where N equals to sample size
Results and discussion
Standardization of the administered phages
It was found that the optimal concentration of applied
phage master mix was 107 PFU/ml. This concentration
gave results pretty similar to that of 106 PFU/ml and better
than higher concentrations (Table 1). On the other hand,
although the phage cocktail in drinking water was refreshed
daily, the phage survival in tap water was measured. It was
found that significant phage decline (>1 log) started only
after 6 d of the preparation of phage-containing drinking
water. This decline in phage concentration was most likely
due to phage decay. Hence, changing the phage-containing
drinking water should be done every 6 days in maximum.
For the sodium bicarbonate added to drinking water, it
was found that 6% concentration w/v was optimal as
higher concentrations affected negatively the life span ofTable 1 Mean LR (log10 CFU/ml) of fecal output of E. coli
in rat animals treated with different concentrations of
phage master mix in drinking water
Phage concentration
PFU/ml in drinking water
Mean LR (log10 CFU/ml)
2 days 4 days
1x103 0 ± 0.0 1.2 ± 0.08
1x104 0.1 ± 0.02 1.2 ± 0.1
1x105 0.3 ± 0.06 1.41 ± 0.17
1x106 0.28 ± 0.07 1.36 ± 0.07
1x107 (optimal) 0.6 ± 0.04 1.8 ± 0.14
1x108 0.6 ± 0.08 1.73 ± 0.2
1x109 0.5 ± 0.04 1.7 ± 0.15
1x1010 0.4 ± 0.09 1.5 ± 0.2phage cocktail while lower concentrations have lower
anti-stomach acid neutralization [data not shown].
Phage biocontrol
Group A (rats with normal intestinal E. coli flora)
Phage feeding via drinking water Single day phage
feeding in drinking water:
The E. coli fecal output started to decline after day 3
from the beginning of phage feeding; the peak of LR of
E. coli was at days four to six. The maximal phage-based
LR of E. coli fecal output was 1.225 log units, which is a
significant reduction. From day seven, the phage-driven
LR of E. coli output was started to vanish and E. coli
count started to rise again reaching 2.sx105 CFU/ml at day
11 which was close to the negative control concentration of
the E. coli output (Table 2).
Continuous phage feeding in drinking water: The re-
sults provided evidence that intestinal E. coli started to
decline after 3 days from the beginning of phage feeding,
the peak of E. coli decline was day 5 to day 7 after the
beginning of phage feeding. Lowest fecal output of E. coli
was 102 CFU/ml while the control load, time zero, was
2×104 CFU/ml. The E. coli phage-driven LR was maximally
2.3 log units at day 7, which is a highly significant decline.
From day 14, the phage-driven LR of E. coli output was
started to vanish and E. coli count started to rise again
reaching 1x104 CFU/ml at day 20 which was close to the
control load of the E. coli output (Table 3).
Continuous phage feeding via drinking water with
alkali: E. coli started to decline after day 2 from the
beginning of phage feeding. The lowest fecal output of
E. coli was 102 CFU/ml at 7th day. The maximal phage-Phage feed at 1×107 PFU/ml





Time zero (control load) 1.8 x 105 -
Day 1 7 x 104 0.4 ± 0.02
Day 2 6.3 x 104 0.45 ± 0.08
Day 3 6.9 x 104 0.39 ± 0.07
Day 4 1.3 x 104 1.11 ± 0.12
Day 5 1 x 104 1.22 ± 0.18
Day 6 1.5 x 104 1.04 ± 0.22
Day 7 4.7 x 104 0.55 ± 0.1
Day 8 1 x 105 0.22 ± 0.08
Day 9 2 x 105 −0.07 ± 0.01
Day 10 2.5 x 105 −0.17 ± 0.06
Day 11 2.2 x 105 −0.1 ± 0.04
Table 3 LR of E. coli fecal output due to the effect of
continuous feeding of phage master mix for 20 d via
drinking water
Phage feed at 1×107 PFU/ml





Time zero (control load) 2 x 104 -
Day 1 2 x 104 0 ± 0.0
Day 2 2.4 x 104 −0.08 ± 0.007
Day 3 1 x 104 0.3 ± 0.01
Day 4 2 x 103 1 ± 0.08
Day 5 2 x 102 2 ± 0.12
Day 6 2 x 102 2 ± 0.15
Day 7 1 x 102 2.3 ± 0.24
Day 8 4 x 102 1.7 ± 0.2
Day 10 6 x 102 1.52 ± 0.18
Day 12 1 x 103 1.3 ± 0.1
Day 14 4.8 x 103 0.61 ± 0.06
Day 16 1 x 103 1.3 ± 0.09
Day 20 1 x 104 0.3 ± 0.04
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decline. From day 14, the phage-driven decline of E. coli
output was started to vanish and E. coli count started to rise
again reaching 3×104 CFU/ml at day 20 which was close to
the control load of the E. coli fecal output (Table 4).
Phage feeding via oral injection
In this method of administration, one protocol was pur-
sued which is continuous feeding of phages for 20 d with
alkali because it proved to be the best protocol in theTable 4 LR of E. coli fecal output due to the effect of
continuous feeding of phage master mix for 20 d via
drinking water with alkali
Phage feed at 1×107 PFU/ml





Time zero (control) 6 x 104 -
Day 1 4 x 104 0.17 ± 0.02
Day 2 2 x 104 0.47 ± 0.03
Day 3 2 x 104 0.47 ± 0.02
Day 4 1 x 103 1.78 ± 0.18
Day 5 1 x 103 1.78 ± 0.09
Day 6 2 x 103 1.47 ± 0.1
Day 7 1 x 102 2.78 ± 0.14
Day 8 2 x 102 2.47 ± 0.22
Day 10 1 x 103 1.78 ± 0.12
Day 12 1 x 103 1.78 ± 0.15
Day 14 1 x 104 0.78 ± 0.08
Day 16 2 x 103 1.47 ± 0.11
Day 20 3 x 104 0.3 ± 0.03phage feeding via water drinking. Rat animals were
injected orally with phage suspension three times a day.
It was found that the baseline E. coli output prior to
phage feeding was 2.3×105 CFU/ml, noticeable decline
started after day 2 and the lowest E. coli count was
found in days 6 to 10, peak of decline was at 6th day,
4×103 CFU/ml when the maximal phage-driven LR of
intestinal E. coli was 1.76 log units. At day 12, E. coli
output started to rise again till reaching 1.2×105 CFU/ml
at day 20 (Table 5).
Phage feeding via oral capsules
In this method of administration, one protocol was pur-
sued which is the continuous feeding. It was found that
the baseline E .coli output prior to phage feeding was
1.8×105 CFU/ml. The decline of E. coli count was max-
imal in days 3 to 10; peak of decline was at 6th day,
1.7×102 CFU/ml when the phage-driven LR of intestinal
E. coli was 3.02 log units. At day 12, E. coli count started
to rise again reaching 2.3 × 104 CFU/ml. (Table 6).
Group B (rats preloaded with human pathogenic E. coli)
This group of rat animals was fed continuously for 20 d
with heavily contaminated 60 human pathogenic isolates.
At the same time, 140 of corresponding lytic bred phages
were given via drinking water, oral injection, and phage-
containing capsules continuously for 20 d.
Baseline fecal output of E. coli in group B rats before phage
feeding (pretreatment)
There was a need to monitor the baseline level of E.
coli output in group B rats that were continuouslyTable 5 LR of E. coli fecal output due to the effect of
continuous feeding of phage master mix for 20 d via oral
injection with alkali
Phage feed at 1×107 PFU/ml





Time zero (control) 2.3 x 105 -
Day 1 1.6x 105 0.15 ± 0.03
Day 2 9 x 104 0.4 ± 0.02
Day 3 1 x 105 0.36 ± 0.07
Day 4 1 x 104 1.36 ± 0.15
Day 5 1 x 105 0.36 ± 0.09
Day 6 4 x 103 1.76 ± 0.18
Day 7 7 x 103 1.51 ± 0.22
Day 8 9 x 103 1.4 ± 0.13
Day 10 8 x 103 1.45 ± 0.1
Day 12 1 x 105 0.36 ± 0.05
Day 14 5 x 104 0.66 ± 0.03
Day 16 5 x 104 0.66 ± 0.06
Day 20 1.2 x 105 0.28 ± 0.04
Table 6 LR of E. coli fecal output due to the effect of
continuous feeding of phage master mix for 20 d via oral
administration of phage-containing capsules
Phage feed at 1×106 PFU/ml via





Time zero (control) 1.8x105 -
Day 1 1.1x 105 0.21 ± 0.04
Day 2 9 x 103 1.3 ± 0.15
Day 3 1 x 103 2.25 ± 0.07
Day 4 8 x 103 1.35 ± 0.2
Day 5 7.6 x 102 2.37 ± 0.16
Day 6 1.7 x 102 3.02 ± 0.22
Day 7 2.8 x 102 2.8 ± 0.18
Day 8 1 x 103 2.25 ± 0.24
Day 10 8 .5x 103 1.32 ± 0.1
Day 12 2.3 x 104 0.89 ± 0.07
Day 14 1 x 104 1.25 ± 0.1
Day 16 1 x 105 0.25 ± 0.05
Day 20 2x105 −0.04 ± 0.006
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water orally without phage cocktail feed. After load-
ing up rat intestines with human pathogenic E. coli,
it was found that E. coli output at day 0 was 2.1 ×
105 CFU/ml and E. coli count started to increase after
24 h, peak of increase was at day 6, 1.1 × 107 CFU/ml
or 1.71 log units. Then, fecal output of E. coli started
to decline reaching 3.4 × 105 CFU/ml at day 20
(Table 7).Table 7 Fecal output of E. coli increased with the effect of
continuous human pathogenic E. coli feeding for 20 d via
drinking water
Pathogenic E. coli feed at 1×108
CFU/ml with water drink for 20 d
Total E. coli output
count (CFU/ml)
Time zero 2.1 x 105
Day 1 2.4x 105
Day 2 3.2x 106
Day 3 7 x 106
Day 4 6.3 x 106
Day 5 8.5 x 106
Day 6 1.1 x 107
Day 7 1 x 107
Day 8 9 x 106
Day 10 8.7x 105
Day 12 7 x 105
Day 14 5.3 x 105
Day 16 5.1 x 104
Day 20 3.4 x 105Phage feeding via drinking water
Rats that were already fed with heavily contaminated 60 E.
coli pathogens, were fed with the phage master mix in sep-
arate feeding bottle simultaneously for 20 d. Since the
protocol of phage feeding with alkali for 20 d was shown as
the best in group A rats, it was the only drinking protocol
pursued in group B rats. It was intended to monitor is
there any decline of the total E. coli output when the
pathogenic E. coli-inoculated rats were fed with the specific
phages of the inoculated pathogens. And whether phage
feeding is able to stop or reverse the E. coli output upsurge.
It was found that phage feeding succeeded in reversing the
upsurge of total E. coli output starting from day 2 and se-
vere lowering of E. coli output was peaked in days 5 to 8;
peak lowering was in day 7, 8.2×102 CFU/ml, when the E.
coli level in the pre-treatment rats was 1×107 CFU/ml.
Therefore, the expected phage-driven LR of E. coli output
was the difference between the E. coli output in group B
rats without phage feeding, 1×107 CFU/ml, and that seen in
group B rats with phage feeding, 8.2×102 CFU/m, namely
4.07 log units. After day 10, the E. coli output started to rise
again reaching 4.6×105 CFU/ml (Table 8).Phage feeding via oral injection
Phage feeding was conducted by oral injections of lambda
buffer solution with 6% w/v Sodium bicarbonate (alkali)
thrice a day for 20 d. It was found that results were rela-
tively similar but a bit less prominent than that of water
drinking protocol done for group B rats. The lowering in
E. coli output was started in day 2; peaked in days 5–8.
The maximal LR was at day 7, 3.45 log units (Table 9).Table 8 E. coli output decline in group B rats due to the
continuous phage feeding for 20 d via water drinking
with alkali
Phage feed at 1×107 PFU/ml
via drinking water for 20 d




Time zero 1.4 x 105 -
Day 1 1.9x 105 0.1 ± 0.03
Day 2 3.5x 105 0.96 ± 0.09
Day 3 4.1x 105 1.23 ± 0.13
Day 4 7.4 x 104 1.93 ± 0.11
Day 5 6.8 x 103 3.09 ± 0.28
Day 6 5.2 x 103 3.32 ± 0.24
Day 7 8.2 x 102 4.08 ± 0.3
Day 8 8.7 x 102 4.01 ± 0.23
Day 10 4x 103 2.33 ± 0.16
Day 12 6.3 x 103 2.04 ± 0.14
Day 14 3 x 104 1.24 ± 0.1
Day 16 5.7 x 105 −1.04 ± 0.06
Day 20 3 x 105 0.05 ± 0.002
Table 9 E. coli output decline due to the continuous
phage feeding for 20 d via oral injection of group B rats
Phage feed at 1×107 PFU/ml
via oral injection for 20




Time zero (control –ve) 2.4 x 106 -
Day 1 2.3x 105 0.01 ± 0.003
Day 2 2.5x 105 1.1 ± 0.08
Day 3 3.2x 105 1.33 ± 0.12
Day 4 7.3 x 104 1.9 ± 0.14
Day 5 4.2 x 104 2.3 ± 0.09
Day 6 8.4 x 103 3.1 ± 0.24
Day 7 3.5 x 103 3.45 ± 0.2
Day 8 8.1 x 103 3.04 ± 0.3
Day 10 5.8x 103 2.17 ± 0.17
Day 12 7.1 x 104 0.99 ± 0.1
Day 14 2 x 105 0.42 ± 0.07
Day 16 7 x 104 −0.13 ± 0.02
Day 20 3 x 105 0.054 ± 0.006
Abdulamir et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:39 Page 8 of 11
http://www.ann-clinmicrob.com/content/13/1/39Phage feeding via oral capsules
Phage feeding was conducted by administering phage-
containing capsules thrice a day for 20 days. It was found
that the lowering in E. coli output was started in day 2;
peaked in days 5–8. The maximal lowering was in day 6,
2.6 ×102 CFU/ml and the peak LR was 4.62 log units. E. coli
output then started to increase after day 10 reaching
5.3×105 CFU/ml at day 20 (Table 10).
Phage shedding during phage feeding
It was found that phage shedding increased gradually
after day 1 and peaked in days 4–12 then it declinedTable 10 E. coli output decline due to the continuous
phage feeding for 20 d via phage-containing capsules
Phage feed at 1×106 PFU/ml
in vegetable capsules for 20 d




Time zero (control –ve) 3.1 x 106 -
Day 1 3.7x 106 −1.18 ± 0.07
Day 2 6.2x 105 0.71 ± 0.05
Day 3 9x 104 1.89 ± 0.13
Day 4 2.8 x 104 2.35 ± 0.21
Day 5 3.2 x 103 3.42 ± 0.026
Day 6 2.6 x102 4.62 ± 0.32
Day 7 3.7 x 102 4.43 ± 0.028
Day 8 6.9 x 102 4.1 ± 0.17
Day 10 7.3x 103 2.07 ± 0.09
Day 12 4.8 x 104 1.16 ± 0.14
Day 14 2.3 x 105 0.36 ± 0.05
Day 16 4.4 x 105 −0.93 ± 0.1
Day 20 5.3x105 −0.19 ± 0.04again which is the reverse pattern seen for E. coli out-
put. There was no remarkable difference between the
pattern of phage shedding between oral injection and
phage-containing water drink (Table 11).
Escherichia coli O157 and other EHEC are believed to
be carried asymptomatically by cattle, cows and sheep
[5]. Shedding of the organism in the faeces of animals is
intermittent and can be exacerbated by a variety of fac-
tors [21] including stress and feed types. Therefore, a
thorough approach is needed to control the microbial
load of the pathogenic E. coli where bovine and other
warm-blooded animal’s feacal contamination is possible.
The ability of phages to recognize precisely their hosts
rendered the use of phages as antibacterial agents favor-
able because of the fact that broad-spectrum antibiotics
kill the target bacteria along with all beneficial bacteria
in the farm or in the organism body [10].
Unfortunately this was the bright side of the story; on
the other hand, phage specificity imposed a complicated
dilemma, which is the difficulty of finding sufficient phage
strains which could cover all or most of bacterial host
strains. Thus, the inability to cover all strains of certain
bacterial species along with the easy development of
evolutionary resistance by the bacteria against their
phages, have made phage therapy or biocontrol is un-
successful [15]. This was worked out by the novel tech-
niques of phage breeding and optimization pursued by
our team [IPO-UK Patent Application No. 0822068].
This prepared the suitable background for formulating
highly lytic and optimized cocktail of large number of
anti- E. coli phages that are able to apply predator effect on
hundreds of target bacteria. For this reason, phage cocktailTable 11 Phage shedding from the studied rats during
phage feeding biocontrol
Phage feed at 1×107
PFU/ml with water drink







Time zero (control –ve) 0 0
Day 1 0 40
Day 2 1.18 x 103 8.0 x 102
Day 3 1.22 x 103 9.4 x 102
Day 4 2.6 x 104 1.2 x 103
Day 5 8.3 x 104 5.2 x 103
Day 6 2.7 x 105 3.8 x 104
Day 7 5.4 x 105 4.1 x 105
Day 8 1.5 x 104 7.9 x 104
Day 10 3.7 x 103 3.8 x 103
Day 12 7.2 x 102 8.7 x 102
Day 14 1.1 x 102 64
Day 16 8.9 6
Day 20 0 0
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control and predate target strains of E. coli whether reside
naturally inside rat animals or artificially inoculated human
pathogenic E. coli in rat guts. The aim of this was to
evaluate the capability of phage cocktail to suppress
the microbial load of E. coli represented by the
reduction in E. coli fecal output. This has special
importance because most cases of transmission of
pathogenic E. coli including O157:H7 are related to fecal
contamination by animals to the food chain [22].
Therefore, it was conceived that decreasing or abolishing
the fecal contamination would decrease largely the
chances for human beings to contract E. coli infection.
Accordingly, in the current study, it was found that
the used phage cocktail was remarkably successful in
lowering the E. coli output of both E. coli flora and ex-
ternally inoculated pathogenic E. coli bacteria in sig-
nificant manner. Three protocols were used of phage
feeding via drinking, phage feeding for one day, for 20
d, and 20 d with alkali. It was found that single day
phage feed was effective but much less efficient than
continuous phage feed for 20 d with or without alkali.
In single day feed, brief E. coli decline for 3 days, 4th
to 6th day and maximal LR was 1.22 log units and then
at 7th day E. coli output began to rise again due to the
loss of the phage lysing effect. In 20 d phage feed, the
decline of E. coli load began after 3 days with extended
lowering phase ranged from 5th days to 10th day and
the maximal LR was 2.3 log units without alkali and
2.78 with alkali. The difference in LR of E. coli between sin-
gle day and 20 d continuous feed was remarkable, 1.56 log
units. This indicated that there was a remarkable enhance-
ment in phage-driven E. coli control by using daily phage
feed rather than one or few days feeding. Moreover, there
was another little enhancement when alkali was used which
could counteract the acidity of rats’ stomach.
On the other hand, using continuous phage feed by oral
injection of phages-containing lambda buffer with alkali
did not give better results as was expected. The oral injec-
tion of phages resulted in 1.02 log units less LR than that
of continuous phage feed via drinking water. This might
be attributed to the frequency of the oral injections of
phages into rats per day. Rats were orally injected thrice a
day and this most probably was less effective than the
available phage-containing drinking water given that rats
drink water, roughly, every 10–15 min which guarantees
undisrupted supply of the phage cocktail. However, it is
expected that more frequent oral injections of phages per
day might lead to much better results. However, the
current study provided evidence that oral injection of
phages is not a practicable option as injecting phages or-
ally needs much efforts and equipment. On the contrary,
feeding phages, at 106 PFU/ml, via vegetable capsules
proved to be superior. Phage containing capsulesadministered 3 times a day succeeded to achieve LR > 3
log units, 3.02, while other routes of demonstration did
not. This might be attributed to the better protection of
phages from stomach acidity than using alkali.
For group B rats, human pathogenic E. coli were fed to
rat animals in parallel with administering specific coli-
phage cocktail in order to measure the potential of the
phage master mix in controlling the externally inocu-
lated pathogenic E. coli as well as the resident E. coli
flora of rats. Rats fed with heavy dose of human patho-
genic E. coli tolerated well these bacteria in that a re-
markable increase was seen in the total E. coli output
after feeding 108 CFU/ml of E. coli daily for 20 d. After
just 6 d of the inoculation of the pathogenic E. coli, the
fecal output of E. coli was 1.8 log units higher than be-
fore; E. coli output increased after 4 to 10 d and this
upsurge of E. coli was then started to decline progres-
sively. Similar to the behavior of the introduced phages, it
is prudent to think that the mucosal immunity of rats’ gut
was responsible for this lowering of E. coli upsurge. How-
ever, our hypothesis is that if rat animals, which were
already loaded with external E. coli, were challenged with
phage feeding specific to the same collection of external
E. coli, then E. coli output upsurge should start to decline
before the immunity develops, before 10th day, just like
the case for the group A rats when the natural E. coli flora
was challenged by phage feeding. A striking E. coli output
lowering was achieved by phage feed for 20 d with alkali
via water drink, oral injection of phage containing lambda
buffer, and phage containing capsules. The fecal output of
E. coli did not increase in rats received phages concomi-
tantly with pathogenic E. coli. Moreover, there was huge
lowering of E. coli output mainly after five to eight d from
phage-bacteria feeding. The peak LR of fecal output of
E. coli was 4.08, 3.45, and 4.62 log units in rats subjected
to 20 d phage feed via drinking water, oral injection, and
capsules respectively. Hence, phage feed reversed the
upsurge of E. coli output. This provided evidence that
phage feed biocontrol is more efficient in combating the
pathogenic non natural E. coli flora than combating natural
flora bacteria. Therefore, phage feed proved to be useful in
suppressing both animals E. coli flora and more efficiently
the external E. coli pathogens in their intestines.
For more confidence in the phage effect in controlling
the residing E .coli inside animals’ intestine, phage
shedding was explored, it was found that phage shed-
ding peaks with the peak decline of E. coli output and
then phage shedding starts to abolish reaching zero at
the end of the third week. There was no significant dif-
ference between phage shedding in animals fed with
phages via water drink or via oral injection. The pattern
seen in this study for phage shedding and phage-driven
E. coli output control was believed to be immune re-
sponse -dependent. Rats developed effective immunity
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pathogenic E. coli isolates. The developed immune reaction
was thought first as E. coli resistance against invading
phages but in vitro plaque assay of E. coli bacteria
isolated from fecal output of rats before and after
phage feeding showed that E. coli bacteria after phage
feeding were as sensitive to the fed phages as E. coli
bacteria isoalted before phage feeding [data not
shown]. Therefore, the gradual loss of the phage-
driven E. coli control was most likely attributed to
immunity development. Moreover, phage shedding
pattern confirmed this explanation as introduced
phages were eliminated gradually at the same period
of introduced bacteria elimination. In addition, it is
noteworthy to mention that some rat animals that
were used in phage feeding two month earlier were
rechallenged again with the same phage cocktail. The
phage biocontrol was null even two months passed
since last time phage feeding was done [data not
shown]. This finding was another proof for the im-
munity hypothesis for the termination of the phage
feeding effect control.
In recent years, there has been an obsessive ques-
tion, whether phages are safe for use in biocontrol or
therapy. No signs or symptoms were found when
phage cocktail was given. It was cautioned that high
number of phages introduced into rat guts might lead
to extensive abolishment of E. coli flora; but, fortu-
nately, it was found that E. coli load was lowered but
not abolished completely in a way that no signs and
symptoms of disturbance in bowel habit was noticed
nor any other change of animals behavior was ob-
served. This was a clue on the harmless use of phages
for lowering E. coli load in animals. Given that such
phage-based biocontrol is conducted only six to eight
days before animal slaughter, say cattle, hence, long-
term adverse effects of using phages might be zero.
The safety of phages was assured by Duckworth and
Gulig [23] who stated that there has been no evi-
dence that exposure to phage particles, even ones
normally associated with disease-causing bacteria, can
actually result in the occurrence of human disease. In
addition, the recent FDA approval of Listeria-specific
bacteriophage preparations for food preservation has
opened the door to new applications of these natural
bacterial killers taken that bacteriophages are viruses
that only infect and lyse bacterial cells and are harm-
less to mammalians [24]. Another safety aspect might
be taken into consideration, phages replicate at the
site of infection or wherever the host bacteria are
present while phages are absent in sterile areas ensur-
ing an optimal self-adjusting dose of phages which is
not found in other modes of non-biological anti-
microbial agents [25].Conclusions
Taken together, it was concluded that phage feed as a
mean of biocontrol for lowering the microbial load of
E. coli bacteria inside animals’ intestine proved to be
successful. The suppression of E. coli output reached 3
log units for rats intestine resident E. coli and 4.62 log
units for both externally inoculated and flora E. coli.
And phage feeding using phage cocktail composed of
high number, 140, of specific bred phages coliphages
ensured the wide coverage of E. coli strains and substrains
leading to efficient E. coli load suppression. Moreover, the
best administration route of phage cocktail was found to
be via vegetables capsules followed by drinking water
which were more efficient that injecting phages directly
into rat throat. In addition, phage cocktail fed continu-
ously for 20 d was the best protocol of feeding and better
to be accompanied by a small percentage of biologically
safe alkali such as Sodium bicarbonate that resulted in
better phage control. The pattern of the phage-based
E. coli biocontrol highlighted that timing of the prehar-
vest animal biocontrol is the most critical step deciding
the success of the phage biocontrol. It was concluded
that the 6th, 7th, and 8th days after the beginning of the
phage feeding were the best days to slaughter the animal
when the highest phage shedding and the lowest E. coli
output were seen. Even though 6th or 7th day might be
better than 8th day, it is preferred to do slaughtering in the
8th day to allow 2 days of minimal E. coli output before
slaughtering. This can ensure that E. coli contamination
into the food chain will be greatly minimized.
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